FDA — authorised 24 September 1981
- Marketing authorisation holder: SCHERING
- Status: approved
FDA authorised Paxipam on 24 September 1981
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 24 September 1981.
SCHERING holds the US marketing authorisation.